Guiding clients through the complexities of initial public offerings, business combination/DE-SPAC transactions, and SEC reporting.
We provide comprehensive support in preparing financial statements, pro forma reporting, and valuation deliverables that meet PCAOB, GAAP, and FASB.
Derivatives & Structured Products Valuation
Our team applies advanced financial modeling techniques—such as Monte Carlo simulations, binomial trees, and closed-form solutions like the Black-Scholes model—to evaluate derivative instruments and structured products. We assist clients in identifying the most suitable valuation methodology for their specific portfolio, supporting both financial reporting and risk management purposes.
SPAC & Equity Instruments Valuation
Special Purpose Acquisition Companies (SPACs) present distinct valuation and reporting challenges. Maenades provides comprehensive valuation services covering warrants, rights, rep shares, convertible notes, private and public units, and underwriter purchase options (UPOs). Our work supports accurate fair value measurement and transparent disclosure in accordance with SEC and PCAOB guidance.
Pro Forma Financial Advisory & De-SPAC
Maenades assists clients through the de-SPAC transaction process, providing end-to-end pro forma financial statement preparation, purchase accounting support, and transaction modeling. Our professionals work closely with management teams, auditors, and legal advisors to ensure the combined entity’s financial presentation aligns with SEC S-4 and Form 8-K requirements.
We help clients:
- Develop pro forma financials reflecting merger adjustments and capital structure changes
- Integrate valuation results into financial reporting and EPS impact analysis
- Support audit and review procedures to meet public company readiness standards
Quantitative Modeling & Business Analytics
Our quantitative finance specialists design and implement customized valuation frameworks and financial models that capture complex assumptions and market dynamics. Whether for purchase price allocation, equity compensation, impairment testing, or regulatory filings, Maenades delivers defensible, data-driven analyses that satisfy both compliance and strategic decision-making needs.